Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies — 100%
myotonia
69%
—
glycogenoses —
84%
dystrophic myotonia
49%
—
myoglobinuria —
81%
neuromyotonia
48%
—
mitochondrial myopathy —
68%
childhood diseases
43%
—
medicinal myopathy —
57%
paroxysmal myoplegia
43%
—
convulsions pain —
56%
lags behind in the development
43%
—
medical thyrotoxicosis —
52%
logorrhea
40%
—
the cause is the effects of alcoholism —
46%
steinert 's disease
39%
—
can not lie still —
46%
sluggish baby
37%
—
itsenko-cushing's disease —
45%
weakness in the legs
36%
—
kidney failure —
44%
birth trauma of the head
36%
—
acromegaly —
44%
can not hold his head
35%
—
Addison's disease —
43%
perinatal encephalopathy
35%
—
consequences of alcoholism —
43%
sucks the breast
35%
—
hyperaldosteronism —
42%
muscle tension
35%
—
gigantism —
42%
paretic gait
34%
—
history of surgery —
41%
head injury
34%
—
convulsions —
41%
damage to the nervous system
34%
—
kidney diseases —
40%
stiffness in the joints
32%
—
consequence of hormone treatment —
39%
flaccid paralysis syndrome
32%
—
uremia —
39%
lack of desires
32%
—
measles —
38%
sad
32%
—
intoxication —
38%
dystrophy
31%
—
vitamin d deficiency —
37%
fatigue from children
30%
—
cardiopulmonary insufficiency —
37%
leg weakness walking
30%
—
violation of thyroid function —
37%
stiffness of movements
30%
—
chronic liver failure —
37%
postencephalitic syndrome
30%
—
violation of pulmonary circulation —
37%
paralysis of the lower extremities
30%
—
pompe disease —
37%
weakness no
30%
—
lipid metabolism —
35%
helps others
30%
—
thyrotoxicosis —
35%
paralysis of the limbs
30%
—
contracture —
35%
cannot relax
30%
—
diffuse toxic goiter —
35%
neurological disorders
29%
—
adrenal insufficiency —
35%
delayed motor development
29%
—
stagnation in the lungs —
35%
increased potassium
28%
—
patient's condition —
35%
weakness in the leg muscles
28%
—
alcoholism —
35%
paresis of legs
28%
—
effects of taking hormones —
34%
myxedema
27%
—
chronic respiratory failure —
34%
neuroinfections
27%
—
cramps in the legs —
34%
trauma
27%
—
enlargement of the thyroid gland —
34%
cns tumors
27%
—
chronic kidney disease —
34%
delayed reaction
27%
—
chronic kidney failure —
34%
delay in physical development
26%
—
myopathy
44%
77%
weakness in the extremities
26%
—
effects of poisoning —
33%
muscle atrophy
26%
—
pituitary gland diseases —
33%
myotonia is congenital
25%
—
hypothyroidism —
33%
delayed speech development
25%
—
liver dysfunction —
33%
traumatic brain injury
25%
—
malabsorption —
33%
encephalopathy
25%
—
liver failure —
33%
head tumor
25%
—
thyroid diseases —
32%
delay of mental development
25%
—
chronic heart failure —
32%
nervous excitability
25%
—
nose pulmonary heart —
32%
no children
24%
—
alcohol dependence —
32%
children's speech
24%
—
enteropathy —
32%
mental retardation
24%
—
respiratory insufficiency —
31%
motor activity
24%
—
protein with increased —
31%
increased motor activity
24%
—
heredity predisposition —
31%
high height
23%
—
congestive kidney —
31%
brain tumor
23%
—
consequences of physical exertion —
31%
organic brain damage
22%
—
not enough time —
30%
quickly gets tired
21%
—
patient is motionless —
30%
joint diseases
21%
—
CHD —
29%
calcium
21%
—
dyspnea —
29%
brain damage
21%
—
there is heart failure —
29%
stage of recovery
20%
—
heart failure —
29%
recovery period
20%
—
liver problems —
28%
swelling
20%
—
metabolic disorder
37%
64%
oncology
18%
—
angiopathy —
27%
rossolimo-steinert-kurschmann dystrophic myotonia
17%
—
up circulatory disorders —
27%
impaired lung function —
27%
heart dysfunction —
26%
consequences of taking medications —
25%
alcoholic myopathy —
23%
muscle weakness
37%
58%
hormonal disorders
29%
48%
weakness after illness
21%
39%
drug disease
19%
36%
oppenheim syndrome
39%
52%
ganglioneuritis
39%
52%
congenital myopathies
39%
52%
inflammatory myopathy
34%
45%
paresis
32%
43%
hypoparathyroidism
32%
43%
periodic paralysis
31%
41%
rickets
28%
38%
lowered
25%
34%
weakness in the hands
28%
37%
increased
18%
24%
inflammation
18%
24%